HMGB1 attenuates the mitigative effect to myocardial ischemia-reperfusion injury by tanshinone ⅡA in rats

doi:10.16352/j.issn.1001-6325.2022.09.1333

Abstract

Abstract: Objective To study the influence of exogenous high-mobility group box 1(HMGB1) on the mitigative effect of tanshinone ⅡA (TSA) to myocardial ischemia-reperfusion (I/R) injury. Methods Rats were divided into sham, I/R (ligation of left anterior descending coronary artery), TSA (I/R + TSA intravenous injection) and TSA+HMGB1 (I/R+TSA intravenous injection + recombination HMGB1 intraperitoneal injection) groups. Serum CK-MB was measured by ELISA. Myocardial infarct area was measured by TCC. The expression of inflammatory indicators were measured by RT-qPCR and Western blot. Results Compared with sham group, CK-MB, myocardial infarct area, transcription level of IL-6, IL-1β and TNF-α, expression of HMGB1, NLRP3 and caspase-1 all increased in I/R group(P＜0.05). Compared with I/R group, CK-MB, myocardial infarct area, transcription levels of IL-6, IL-1β and TNF-α, expressions of HMGB1, NLRP3, caspase-1 and NF-κB decreased in TSA group (P＜0.05). However, compared with TSA group, CK-MB, myocardial infarct area, transcription levels of IL-6, IL-1β and TNF-α, expressions of HMGB1, NLRP3, caspase-1 and NF-κB increased in TSA+HMGB1 group(P＜0.05). Conclusions Exogenous HMGB1 attenuates the mitigative effect of tanshinone ⅡA to rat myocardial I/R injury through up-regulation the expressions of inflammatory factors.

Key words: high-mobility group box 1, tanshinone ⅡA, myocardial ischemia-reperfusion injury, inflammatory factor

CLC Number:

R543.3

ZHONG Jin-peng, YANG Li, WANG Hui-bo,CHEN Hong-jian, LI Jin-wei, WEN Ming-hong, LYU Yun-bo. HMGB1 attenuates the mitigative effect to myocardial ischemia-reperfusion injury by tanshinone ⅡA in rats[J]. Basic & Clinical Medicine, 2022, 42(9): 1333-1338.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.09.1333

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I9/1333

References 15

[1]	Wei B, Li WW, Ji J, et al. The cardioprotective effect of sodium tanshinone IIA sulfonate and the optimizing of therapeutic time window in myocardial ischemia/reperfusion injury in rats[J]. Atherosclerosis, 2014,235:318-327.
[2]	Hu H, Zhai C, Qian G, et al. Protective effects of tanshinone IIA on myocardial ischemia reperfusion injury by reducing oxidative stress, HMGB1 expression, and inflammatory reaction[J]. Pharm Biol, 2015,53:1752-1758.
[3]	Raucci A, Di MS, Scavello F, et al. The Janus face of HMGB1 in heart disease: a necessary update[J]. Cell Mol Life Sci, 2019,76:211-229.
[4]	Lin Y, Chen L, Li W, et al. Role of high-mobility group box-1 in myocardial ischemia/reperfusion injury and the effect of ethyl pyruvate[J]. Exp Ther Med, 2015,9:1537-1541.
[5]	Abarbanell AM, Hartley JA, Herrmann JL, et al. Exogenous high-mobility group box 1 improves myocardial recovery after acute global ischemia/reperfusion injury[J]. Surgery, 2011,149:329-335.
[6]	Wang JG, Bondy SC, Zhou L, et al. Protective effect of tanshinone IIA against infarct size and increased HMGB1, NFκB, GFAP and apoptosis consequent to transient middle cerebral artery occlusion[J]. Neurochem Res, 2014,39:295-304.
[7]	Li X, Wu Y, Zhang W, et al. Pre-conditioning with tanshinone IIA attenuates the ischemia/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells[J]. Biomed Pharmacother, 2017,89:1392-1400.
[8]	Andrassy M, Volz HC, Igwe JC, et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart[J]. Circulation, 2008,117:3216-3226.
[9]	Andrassy M, Volz HC, Riedle N, et al. HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction[J]. J Intern Med, 2011,270:245-253.
[10]	Tian Y, Pan D, Chordia MD, et al. The spleen contributes importantly to myocardial infarct exacerbation during post-ischemic reperfusion in mice via signaling between cardiac HMGB1 and splenic RAGE[J]. Basic Res Cardiol, 2016,111:62-84.
[11]	van Hout GP, Bosch L, Ellenbroek GH, et al. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction[J]. Eur Heart J, 2017,38:828-836.
[12]	Dong LY, Chen F, Xu M, et al. Quercetin attenuates myocardial ischemia-reperfusion injury via downregulation of the HMGB1-TLR4-NF-κB signaling pathway[J]. Am J Transl Res, 2018,10:1273-1283.
[13]	Loukili N, Rosenblatt-Velin N, Li J, et al. Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo[J]. Cardiovasc Res, 2011,89:586-594.
[14]	Hu X, Jiang H, Cui B, et al. Preconditioning with high mobility group box 1 protein protects against myocardial ischemia-reperfusion injury[J]. Int J Cardiol, 2010,145:111-112.
[15]	Xue J, Suarez JS, Minaai M, et al. HMGB1 as a therapeutic target in disease[J]. J Cell Physiol, 2021,236:3406-3419.